A study conducted in Nepal by Mittal et al. conveyed that 17% of the population had NAFLD; attributable to increased concentrations of serum alanine aminotransferase and aspartate aminotransferase (1). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.